Structural and Functional Characterization of Human Stem-Cell-Derived Retinal Organoids by Live Imaging
Source Browne et al., 2017 · USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine of the University of Southern California · 10.1167/iovs.16-20796
Abstract
This protocol characterizes hESC- and iPSC-derived retinal organoids using multimodal live imaging techniques including phase contrast microscopy, optical coherence tomography (OCT), fluorescence lifetime imaging microscopy (FLIM), and hyperspectral imaging (HSpec). The methods enable nondestructive assessment of retinal organoid structure and metabolic state during development into lamellar structures with photoreceptors.
Protocol overview
20 steps across 8 phases
- 1 Culture hESC and iPSC and initiate differentiation into retinal organoids
- 2 Prepare organoids for live imaging
- 1 Acquire phase contrast photomicrographs
- 1 Suspend organoids in culture media
- 2 Perform OCT imaging with Spectralis system
- 1 Acquire spectral images with 2-photon microscopy
- 2 Perform phasor analysis of spectral data
- 3 Quantify biomolecule distribution by region of interest (ROI)
- 1 Acquire fluorescence lifetime images
- 2 Generate phasor plot from FLIM data
- 3 Perform image segmentation and regional analysis
- 4 Quantify metabolic changes by free/bound NADH ratio
- 1 Perform histologic staining
- 1 Fix organoid tissue in formalin
- 2 Stain with Lugol iodine for contrast enhancement
- 3 Image with microCT immediately after staining
- 4 Perform high-resolution 3D scans
- 5 Reconstruct 3D images from CT data
- 1 Analyze 2-photon light microscopy data
- 2 Calculate statistical significance
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Browne et al., 2017. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol